510(k) · Cleared
ClearedBinax Nowr Streptococcus Pneumoniae Urinary Antigen Test (22 Test Kit),(12 Test Kit), Binax Nowr Streptococcus Pneumoni
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Binax, Inc. · GTZ Antisera, All Groups, Streptococcus Spp.
Cleared on Aug 27, 1999 as substantially equivalent to K854852 (Wellcome Diagnostics, 1986) after a 99-day review. Its family tree reaches back 1 generation to 1986. 1 later device descends from it.
- Decided
- Aug 27, 1999
- Review
- 99 days
- Class
- Class I
- Product code
- GTZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K854852 (1986). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK854852 Wellcogen Bacterial Antigen KitWellcome Diagnostics · 1986
- This deviceK991726 Binax Nowr Streptococcus Pneumoniae Urinary Antigen Test (22 Test…Binax, Inc. · 1999
- Descendant · cites it directly · 0 of its ownK191184 ImmuView S pneumoniae and L pneumophila Urinary Antigen TestSsi Diagnostica A/S · 2020
Most influential descendants
Showing 1 of 1 · See all- K191184ImmuView S pneumoniae and L pneumophila Urinary Antigen TestSsi Diagnostica A/S · 2020 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K854852 | Wellcogen Bacterial Antigen Kit | Wellcome Diagnostics | 1986 | — |
| 0 (this device) | K991726 | Binax Nowr Streptococcus Pneumoniae Urinary Antigen Test (22 Test Kit),(12… | Binax, Inc. | 1999 | — |
| +1 | K191184 | ImmuView S pneumoniae and L pneumophila Urinary Antigen Test | Ssi Diagnostica A/S | 2020 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2020 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K854852 | Wellcogen Bacterial Antigen KitSummary page 1…igen Test Strep pneumo ICT, Binax NOW® Strep pneumo test Streptococcus spp. serological reagents (per 21 CFR 8660.3740) Wellcogen Bacterial Antigen Kit, 510(k) number K854852 The Binax NOW® Streptococcus pneumoniae lrinary Antigen Test is an immunochromatographic membrane assay used to detect Streptoc… | 1986 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K191184 | ImmuView S pneumoniae and L pneumophila Urinary Antigen Test | 2020 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All GTZ devicesGTZ Antisera, All Groups, Streptococcus Spp.: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GTZ
FDA has decided no GTZ device since 2007.
Median 510(k) review, days · GTZ
Too few GTZ 510(k)s in any year since 2007 to give a median.
Recalls per year · GTZ
1in 2009
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GTZ
10in 2025
MAUDE reports naming product code GTZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 1 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 2 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 1 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 0 | — | 0 | 2 |
| 2018 | 0 | — | 0 | 8 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 4 |
| 2025 | 0 | — | 0 | 10 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Binax Now® Streptococcus pneumoniae Urinary Antigen Test is a rapid immunochromatographic assay for the detection of Streptococcus pneumoniae in human urine as an adjunct to culture for the presumptive diagnosis of pneumococcal pneumonia. It is intended for in vitro diagnostic use.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K991726 · printed Nov 4, 2026
Cite this page
510(k) Report. “K991726: Binax Nowr Streptococcus Pneumoniae Urinary Antigen Test (22 Test Kit),(12 Test Kit), Binax Nowr Streptococcus Pneumoni.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991726
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026